Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Priorix versus M-M-R II/VaxPro as first-dose MMR vaccine in toddlers with concomitant varicella, hepatitis A, and US-subset pneumococcal vaccination
2011-006161-18Phase 3Completed
- Sponsor
- GSK
- Start
- Jul 2014
- Modality
- Live Attenuated Vaccines → Live Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of measles, mumps and rubella vaccine (live), M-M-R II, measles, mumps, and rubella vaccine (live) in measles, mumps, rubella, chickenpox, hepatitis A (HAV), sponsored by GSK. Started Jul 2014; status: completed.
02
Drugs
measles, mumps and rubella vaccine (live)M-M-R IImeasles, mumps, and rubella vaccine (live)
03
Conditions
measlesmumpsrubellachickenpoxhepatitis A (HAV)
Beyond the preview
Go deeper on 2011-006161-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-006161-18.